With the FDA clearance of an investigational new drug application, a phase 1 clinical trial evaluating NST-628 will start in mid-2024.
March 2024 Brief
Here is a look back at all the FDA happenings of March 2024.
With the FDA clearance of an investigational new drug application, a phase 1 clinical trial evaluating NST-628 will start in mid-2024.
Here is a look back at all the FDA happenings of March 2024.